i was kinda focussing on the hfref surrogate. they released this a while back suggesting/hoping it may be considered an appropriate endpoint.
with the encouraging feedback from meeting it sounds like they may get their wish. i wonder how much big pharma would have to take notice.
well they have a cartoon for proposed moa so must be fairly well described
Ann: Half Year Financial Results Presentation, page-76
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.000(0.00%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.11 | $1.05 | $4.386M | 4.063M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 59999 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 16930 | 4 |
View Market Depth
| Last trade - 15.27pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.000 ( 0.36 %) |
||||
| Open | High | Low | Volume | ||
| $1.09 | $1.11 | $1.06 | 998496 | ||
| Last updated 15.45pm 14/06/2024 ? | |||||
| MSB (ASX) Chart |